cResults — with a diversified staff of operational consultants, engineers and technical experts — can help the pharmaceutical, biotechnology, and medical device industries meet these goals while ensuring compliance and adherence to tough regulatory and competitive demands.

When required, we team up with IPS to provide additional services and provide the desired feasibility checks along with the recommendations. Once the improvement work plan is approved by the client team, cResults will support the implementation process with the needed SME to deliver the desired results and boost client operating performance.

In today's intense business environment, there is an increase in competition from low-cost generic drug manufacturers. Industry giants are subsequently losing sales, putting the $400 billion per year drug industry in jeopardy. As a results of these pressures and the overall economic situation, the importance of low-cost and efficient operation manufacturing, packaging, and quality groups are becoming more significant to the existing margin contributions. Operational challenges such as inventory and cost reduction, cycle time reduction, improved delivery consistency, and schedule adherence have been recognized by corporate leaders as imperative issues that need to be addressed immediately.